Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era

Christopher F. Theriau, Yuchen Li, Deborah Akurang, Sara M. Moore, Rosalyn A. Juergens, Natasha B. Leighl, Paul Wheatley-Price

Open source

DOI
10.3390/curroncol33050277
Published
05
Container
Current Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33050277,
  title = {Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era},
  author = {Christopher F. Theriau and Yuchen Li and Deborah Akurang and Sara M. Moore and Rosalyn A. Juergens and Natasha B. Leighl and Paul Wheatley-Price},
  year = {2026},
  journal = {Current Oncology},
  doi = {10.3390/curroncol33050277},
  url = {https://doi.org/10.3390/curroncol33050277}
}

RIS

TY  - JOUR
TI  - Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era
AU  - Christopher F. Theriau
AU  - Yuchen Li
AU  - Deborah Akurang
AU  - Sara M. Moore
AU  - Rosalyn A. Juergens
AU  - Natasha B. Leighl
AU  - Paul Wheatley-Price
PY  - 2026
JO  - Current Oncology
DO  - 10.3390/curroncol33050277
UR  - https://doi.org/10.3390/curroncol33050277
ER  - 

APA

Theriau, C. F., Li, Y., Akurang, D., Moore, S. M., Juergens, R. A., Leighl, N. B., & Wheatley-Price, P. (2026). Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era. Current Oncology. https://doi.org/10.3390/curroncol33050277

Source records